Kirby McInerney LLP is investigating potential claims against the Board of Directors of ArthroCare Corporation (“ArthroCare” or the “Company”) (NASDAQ:ARTC) concerning the proposed acquisition of the Company by Smith & Nephew PLC (“Smith”) (NYSE:SNN). Under the terms of the definitive merger agreement, ArthroCare stockholders will receive $48.25 in cash for each share of ArthroCare owned, valuing the transaction at approximately $1.7 billion.

The investigation concerns whether the ArthroCare Board of Directors violated its fiduciary duties by agreeing to the proposed transaction and whether the $48.25 per share proposed consideration adequately values ArthroCare’s common stock.

If you are an ArthroCare stockholder and wish to obtain additional information, please contact J. Brandon Walker, Esq. by email at bwalker@kmllp.com, by telephone at (212) 699-1145 or (888) 529-4787, or by filling out this contact form. There is no cost or obligation to you.

Kirby McInerney LLP is a New York-based law firm concentrating in securities, shareholder, whistleblower, antitrust and consumer litigation. For additional information, please go to www.kmllp.com.

Kirby McInerney LLPJ. Brandon Walker, Esq., 212-699-1145888-529-4787bwalker@kmllp.com

Arthrocare Corp. (MM) (NASDAQ:ARTC)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Arthrocare Corp. (MM) Charts.
Arthrocare Corp. (MM) (NASDAQ:ARTC)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Arthrocare Corp. (MM) Charts.